This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Washington University. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Matthew Cooper
Introduction
Matthew Cooper is a prominent inventor based in St. Louis, MO (US). He has made significant strides in the field of gene editing, particularly in the treatment of T cell malignancies. With a total of 4 patents to his name, Cooper's work is paving the way for advancements in medical therapies.
Latest Patents
One of Matthew Cooper's latest patents focuses on the "Gene Editing of CAR-T Cells for the Treatment of T Cell Malignancies with Chimeric Antigen Receptors." This innovative approach aims to enhance the efficacy of CAR-T cell therapies, which are crucial in treating various forms of cancer.
Career Highlights
Cooper's career is marked by his dedication to research and innovation. He is affiliated with Washington University, where he continues to explore groundbreaking techniques in gene therapy. His work has garnered attention for its potential to revolutionize cancer treatment.
Collaborations
Matthew Cooper collaborates with esteemed colleagues, including John F. Dipersio and Alun Carter. These partnerships enhance the research environment and contribute to the development of effective therapeutic strategies.
Conclusion
In summary, Matthew Cooper's contributions to gene editing and cancer treatment are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile